These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28836489)

  • 1. Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine.
    Liu GF; Hille D; Kaplan SS; Goveia MG
    Hum Vaccin Immunother; 2017 Oct; 13(10):2357-2363. PubMed ID: 28836489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of pentavalent rotavirus vaccine in Chinese infants.
    Mo Z; Ma X; Luo P; Mo Y; Kaplan SS; Shou Q; Zheng M; Hille DA; Arnold BA; ; Liao X
    Vaccine; 2019 Mar; 37(13):1836-1843. PubMed ID: 30808567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of the pentavalent rotavirus vaccine in African infants.
    Armah GE; Breiman RF; Tapia MD; Dallas MJ; Neuzil KM; Binka FN; Sow SO; Ojwando J; Ciarlet M; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A86-93. PubMed ID: 22520142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
    Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
    Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects.
    Lawrence J; He S; Martin J; Schödel F; Ciarlet M; Murray AV
    Hum Vaccin Immunother; 2014; 10(8):2247-54. PubMed ID: 25424929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy.
    Patel M; Glass RI; Jiang B; Santosham M; Lopman B; Parashar U
    J Infect Dis; 2013 Jul; 208(2):284-94. PubMed ID: 23596320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
    Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentavalent rotavirus vaccine in infants with surgical gastrointestinal disease.
    McGrath EJ; Thomas R; Duggan C; Asmar BI
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):44-8. PubMed ID: 24614127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postvaccination Serum Antirotavirus Immunoglobulin A as a Correlate of Protection Against Rotavirus Gastroenteritis Across Settings.
    Baker JM; Tate JE; Leon J; Haber MJ; Pitzer VE; Lopman BA
    J Infect Dis; 2020 Jun; 222(2):309-318. PubMed ID: 32060525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
    Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
    Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.
    Levin MJ; Lindsey JC; Kaplan SS; Schimana W; Lawrence J; McNeal MM; Bwakura-Dangarembizi M; Ogwu A; Mpabalwani EM; Sato P; Siberry G; Nelson M; Hille D; Weinberg GA; Weinberg A
    AIDS; 2017 Jan; 31(1):49-59. PubMed ID: 27662551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M; Schödel F
    Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countries.
    El Khoury AC; Mast TC; Ciarlet M; Markson LE; Goveia MG
    Hum Vaccin; 2011 May; 7(5):506-10. PubMed ID: 21422820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5).
    Itzler R; Koch G; Matson DO; Gothefors L; Van Damme P; Dinubile MJ; Heaton PM
    BMC Pediatr; 2010 Jun; 10():42. PubMed ID: 20540778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.
    Cheuvart B; Neuzil KM; Steele AD; Cunliffe N; Madhi SA; Karkada N; Han HH; Vinals C
    Hum Vaccin Immunother; 2014; 10(2):505-11. PubMed ID: 24240068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).
    Dennehy PH; Vesikari T; Matson DO; Itzler RF; Dallas MJ; Goveia MG; DiNubile MJ; Heaton PM; Ciarlet M
    Hum Vaccin; 2011 May; 7(5):563-8. PubMed ID: 21441783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
    Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
    Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
    Danchin M; Kirkwood CD; Lee KJ; Bishop RF; Watts E; Justice FA; Clifford V; Cowley D; Buttery JP; Bines JE
    Vaccine; 2013 May; 31(23):2610-6. PubMed ID: 23597719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.